Patents by Inventor Lucia Desser

Lucia Desser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of ocular diseases
    Patent number: 9795656
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of ocular diseases related to neoangiogenesis selected from the group consisting of age related macular degeneration (AMD), choroidal neovascularization, Hippel-Lindau Disease, iris neovascularization, ischemic proliferative retinopathy, neovascularization of the Cornea, and proliferative sickle cell retinopathy, wherein the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases.
    Type: Grant
    Filed: August 16, 2007
    Date of Patent: October 24, 2017
    Assignee: MARLYN NUTRACEUTICALS INC
    Inventors: Ahmed Aftab, Lucia Desser, Bernhard Lotz, Thomas Mohr
  • Pharmaceutical preparation for treating benign prostatic hyperplasia
    Patent number: 8231870
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of benign prostate hypertrophy/hyperplasia, wherein the medicament is adapted for enteral administration, the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases and the at least one protease is administered in an amount of 1 to 100 mg/kg body weight.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: July 31, 2012
    Assignee: Volopharm GmbH
    Inventors: Lucia Desser, Bernhard Lotz, Thomas Mohr
  • TREATMENT OF OCULAR DISEASES
    Publication number: 20110311509
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of ocular diseases related to neoangiogenesis selected from the group consisting of age related macular degeneration (AMD), choroidal neovascularisation, Hippel-Lindau Disease, iris neovascularisation, ischemic proliferative retinopathy, neovascularisation of the Cornea, and proliferative sickle cell retinopathy, wherein the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases.
    Type: Application
    Filed: August 16, 2007
    Publication date: December 22, 2011
    Applicant: MARLYN NUTRACEUTICALS,INC.
    Inventors: Ahmed Aftab, Lucia Desser, Bernhard Lotz, Thomas Mohr
  • PHARMACEUTICAL PREPARATION FOR TREATING BENIGN PROSTATIC HYPERPLASIA
    Publication number: 20100254968
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of benign prostate hypertrophy/hyperplasia, wherein the medicament is adapted for enteral administration, the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases and the at least one protease is administered in an amount of 1 to 100 mg/kg body weight.
    Type: Application
    Filed: December 3, 2008
    Publication date: October 7, 2010
    Applicant: Volopharm GmbH
    Inventors: Lucia Desser, Bernhard Lotz, Thomas Mohr